RKDAArcadia Biosciences, Inc.同业对比
Arcadia Biosciences, Inc. 与SIC 1311 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RKDA本股 | $1M#8 | — | 0.2x#1 | 0.2x#2 | -3.7%#5 | 66.8%#6 | -51.5%#10 | -37.6%#8 | — | — | -87.7%#10 | — |
| AGIG | $53M#1 | — | 3.3x#8 | 129.0x#8 | -26.7%#11 | -716.2%#13 | -7000.8%#13 | -180.8%#10 | -104.4%#6 | — | -82.0%#9 | 0.1%#2 |
| PROP | $46M#2 | — | 0.2x#2 | 0.2x#1 | 2943.8%#1 | 178.3%#2 | 27.1%#3 | 14.4%#1 | 6.4%#1 | 5#1 | -80.4%#8 | — |
| EONR | $31M#3 | — | 0.5x#3 | 1.6x#4 | — | — | -19.8%#9 | -13.3%#6 | -3.5%#3 | — | 55.7%#1 | — |
| CKX | $23M#4 | 8.0x#2 | 1.1x#5 | 28.0x#7 | -44.9%#12 | 1102.9%#1 | 434.2%#1 | 13.9%#2 | — | — | -4.8%#4 | — |
| MXC | $22M#5 | 14.4x#3 | 1.1x#6 | 3.4x#5 | -8.1%#7 | -23.7%#9 | 19.4%#4 | 6.4%#3 | 4.9%#2 | — | 26.8%#3 | 0.9%#1 |
| BRN | $15M#6 | — | 1.7x#7 | 1.1x#3 | -24.2%#10 | -27.6%#10 | 0.2%#7 | -80.1%#9 | — | — | -7.6%#5 | — |
| GBR | $4M#7 | — | 0.9x#4 | 24.9x#6 | 6.2%#4 | -155.6%#12 | -171.0%#12 | -1.0%#5 | -6.2%#5 | — | -30.5%#7 | — |
| ALTX | — | — | — | — | -21.7%#9 | -143.9%#11 | — | -14.9%#7 | — | — | — | — |
| ANNA | — | 17.8x#4 | — | — | 1663.0%#2 | 123.2%#3 | 11.6%#5 | — | — | — | -20.7%#6 | — |
| ANNAW | — | 1.6x#1 | — | — | 1663.0%#2 | 123.2%#3 | 11.6%#5 | — | — | — | 40.9%#2 | — |
| APHD | — | — | — | — | -100.0%#14 | 45.9%#7 | — | -1565.5%#11 | — | — | — | — |
| BDCO | — | — | — | — | -12.0%#8 | — | -0.5%#8 | 0.0%#4 | -4.4%#4 | — | — | — |
| BSM | — | — | — | — | -3.9%#6 | 10.5%#8 | 73.0%#2 | — | — | — | — | — |
| CEIN | — | — | — | — | -78.2%#13 | 93.5%#5 | -127.6%#11 | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议